Methyl 5,6,7,8-tetrahydro-1,5-naphthyridine-2-carboxylate, 98%, 100mg

3-Pyridylacetic Acid Hydrochloride>99.0%(T)25g

5-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxylic acid, 98%, 1g

4-BROMO-5,6-DIMETHYL-1H-INDAZOLE, 95%, 10g

5-Hydroxy-1H-pyridin-2-one, 95.0%, 25g

6-Formylpicolinic acid, 95.0%, 250mg

Natriumhypochloritlösung, 12 % Cl, 2.5 l, kunststoffverpackung.

(2E)-1-(3-bromophenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 10g

(3-Bromopyridin-4-yl)carbamic acid tert-butyl ester, 95.0%, 10g

tert-butyl 2-(4-methoxyphenyl)-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate, 5mg

ethyl 1H,2H,3H-pyrazolo[1,5-a]imidazole-7-carboxylate, 95.0%, 250mg

5-Methoxy-1H-pyrrolo[3,2-b]pyridine, 95.0%, 5g

5-chloro-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid, 95+%, 5g